The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical study evaluating the efficacy and safety of disitamab vedotin combined with sintilimab and S-1 in the conversion treatment of HER2-overexpression unresectable gastric cancer.
 
Han Liang
No Relationships to Disclose
 
Xiaona Wang
No Relationships to Disclose
 
Liang Shang
No Relationships to Disclose
 
Xiaodong Chen
No Relationships to Disclose
 
Xiangdong Cheng
No Relationships to Disclose
 
Ziyu Li
No Relationships to Disclose
 
Bo Wei
No Relationships to Disclose
 
Zhichao Zheng
No Relationships to Disclose
 
Guoxin Li
No Relationships to Disclose
 
Gang Ji
No Relationships to Disclose
 
Zizhen Zhang
No Relationships to Disclose
 
Yantao Tian
No Relationships to Disclose
 
Qun Zhao
No Relationships to Disclose
 
Lin Yang
No Relationships to Disclose
 
Heli Liu
No Relationships to Disclose
 
Hao Chen
No Relationships to Disclose
 
Yanliang Liu
No Relationships to Disclose